ReviewOpen access Macedonian journal of medical sciences2018

Chimeric Monoclonal Antibody Cetuximab Targeting Epidermal Growth Factor-Receptor in Advanced Non-Melanoma Skin Cancer.

Uwe Wollina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.